Johnson & Johnson Recall 57 thousand Bottles Topamax

The emergence of complaints from consumers, the scent is not fair on the product Topamax, Johnson & Johnson recall the sale of about 57 thousand bottles epilepsy drug from the market on Thursday (04/14/2011).

Epilepsy drug tablet form, Topamax, 100 mg manufactured by pharmaceutical company Ortho-McNeil Neurologics, one branch of Johnson & Johnson company. The drug was delivered and distributed between October 19, 2010 and December 28, 2010 in the United States and Puerto Rico.

Until now, there are four customers who complained about the smell unnatural allegedly caused by chemicals (2,4,6 tribromoanisole) used to store the packaging of drugs, said the Johnson & Johnson, as quoted by Xinhua (4/15/2011).

Withdrawal of the product is not expected to cause a shortage of products on the market, said Ortho-McNeil Neurologics.

Similar complaints about the smell of damp and moldy also has led to recall of millions of bottles of Tylenol, Motrin, and Benadryl.